The efficacy of oral corticosteroids for treatment of Tietze syndrome: A pragmatic randomized controlled trial.
Hany Hasan ElsayedIhab AliMohammed Abdel-GayedAly Mohamad WardaAssem Adel MoharramPublished in: Journal of clinical pharmacy and therapeutics (2022)
In this study, addition of short-term oral corticosteroids showed a clear benefit for use at 1, 2 and 3 weeks in improvement of pain and QOL in patients with Tietze syndrome. This difference was maintained at mid-term follow up after treatment cessation. This facilitates the advantage of using steroids as well as excluding their side effects for an accepted timeframe.